LifeStance Health Group (Nasdaq: LFST) announced that certain selling stockholders plan to offer 25,000,000 shares of common stock, with the company not receiving any proceeds from this sale. Concurrently, LifeStance has authorized the repurchase of 7,000,000 shares from the underwriter, J.P. Morgan, at the same price as the offering, provided the offering completes. Historically, similar secondary offerings have led to significant stock price drops, though the current reaction has been milder.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Existing LifeStance investors to sell 25M shares as company buys back 7M
LifeStance Health Group (Nasdaq: LFST) announced that certain selling stockholders plan to offer 25,000,000 shares of common stock, with the company not receiving any proceeds from this sale. Concurrently, LifeStance has authorized the repurchase of 7,000,000 shares from the underwriter, J.P. Morgan, at the same price as the offering, provided the offering completes. Historically, similar secondary offerings have led to significant stock price drops, though the current reaction has been milder.